Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Cyclosporin showed no clear difference in kidney failure compared with different comparators (low certainty).
Low‐molecular‐weight heparin showed no clear difference in PE: assessed by CT arteriography ( compared with no prophylaxis (moderate certainty).
Low‐molecular‐weight heparin showed no clear difference in symptomatic DVT: assessed by presence of symptoms and confirmed by a… compared with no prophylaxis (low certainty).
It is very uncertain whether low‐molecular‐weight heparin changes asymptomatic DVT: compared with no prophylaxis (very low certainty).
Low‐molecular‐weight heparin showed no clear difference in all adverse effects, including allergies at injection site, minor… compared with no prophylaxis (moderate certainty).
Low‐molecular‐weight heparin showed no clear difference in major bleeding ( compared with no prophylaxis (moderate certainty).
Low‐molecular‐weight heparin showed no clear difference in minor bleeding ( compared with no prophylaxis (moderate certainty).
The review found no eligible studies for this question.
Mefanamic acid showed no clear difference in side effects: nausea compared with vitex agnus; GRADE not reported.
Mefanamic acid showed no clear difference in side effects: abdominal pain compared with vitex agnus; GRADE not reported.
It is very uncertain whether tranexamic acid changes pelvic pain compared with sodium diclofenac (very low certainty).
The review found no eligible studies for this question.
Naproxen showed no clear difference in need for additional analgesia (self‐recorded) compared with placebo (low certainty).
Naproxen showed no clear difference in side effects: gastrointestinal symptoms compared with placebo (low certainty).